Literature DB >> 31160346

Attitudes toward Precision Treatment of Smoking in the Southern Community Cohort Study.

Nicole Senft1, Maureen Sanderson2, Rebecca Selove3, William J Blot4, Stephen King4, Karen Gilliam4, Suman Kundu4, Mark Steinwandel4, Sarah J Sternlieb4, Shaneda Warren Andersen4,5, Debra L Friedman4, Erin Connors3, Mary Kay Fadden2, Matthew Freiberg4,6, Quinn S Wells4, Juan Canedo2, Rachel F Tyndale7,8, Robert P Young9, Raewyn J Hopkins9, Hilary A Tindle4,6.   

Abstract

BACKGROUND: Precision interventions using biological data may enhance smoking treatment, yet are understudied among smokers who are disproportionately burdened by smoking-related disease.
METHODS: We surveyed smokers in the NCI-sponsored Southern Community Cohort Study, consisting primarily of African-American, low-income adults. Seven items assessed attitudes toward aspects of precision smoking treatment, from undergoing tests to acting on results. Items were dichotomized as favorable (5 = strongly agree/4 = agree) versus less favorable (1 = strongly disagree/2 = disagree/3 = neutral); a summary score reflecting generalized attitudes was also computed. Multivariable logistic regression tested independent associations of motivation (precontemplation, contemplation, and preparation) and confidence in quitting (low, medium, and high) with generalized attitudes, controlling for sociodemographic factors and nicotine dependence.
RESULTS: More than 70% of respondents endorsed favorable generalized attitudes toward precision medicine, with individual item favorability ranging from 64% to 83%. Smokers holding favorable generalized attitudes reported higher income and education (P < 0.05). Predicted probabilities of favorable generalized attitudes ranged from 63% to 75% across motivation levels [contemplation vs. precontemplation: adjusted odds ratio (AOR) = 2.10, 95% confidence interval (CI), 1.36-3.25, P = 0.001; preparation vs. precontemplation: AOR = 1.83, 95% CI, 1.20-2.78, P = 0.005; contemplation vs. preparation: AOR = 1.15, 95% CI, 0.75-1.77, P = 0.52] and from 59% to 78% across confidence (medium vs. low: AOR = 1.91, 95% CI, 1.19-3.07, P = 0.007; high vs. low: AOR = 2.62, 95% CI, 1.68-4.10, P < 0.001; medium vs. high: AOR = 0.73, 95% CI, 0.48-1.11, P = 0.14).
CONCLUSIONS: Among disproportionately burdened community smokers, most hold favorable attitudes toward precision smoking treatment. Individuals with lower motivation and confidence to quit may benefit from additional intervention to engage with precision smoking treatment. IMPACT: Predominantly favorable attitudes toward precision smoking treatment suggest promise for future research testing their effectiveness and implementation. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31160346      PMCID: PMC6679740          DOI: 10.1158/1055-9965.EPI-19-0179

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  38 in total

Review 1.  Evaluating the public health impact of health promotion interventions: the RE-AIM framework.

Authors:  R E Glasgow; T M Vogt; S M Boles
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

2.  The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change.

Authors:  C C DiClemente; J O Prochaska; S K Fairhurst; W F Velicer; M M Velasquez; J S Rossi
Journal:  J Consult Clin Psychol       Date:  1991-04

3.  The Southern Community Cohort Study: investigating health disparities.

Authors:  Lisa B Signorello; Margaret K Hargreaves; William J Blot
Journal:  J Health Care Poor Underserved       Date:  2010-02

Review 4.  General practitioners' and family physicians' negative beliefs and attitudes towards discussing smoking cessation with patients: a systematic review.

Authors:  Florian Vogt; Sue Hall; Theresa M Marteau
Journal:  Addiction       Date:  2005-10       Impact factor: 6.526

5.  Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 National Health Interview Survey.

Authors:  Vilma E Cokkinides; Michael T Halpern; Elizabeth M Barbeau; Elizabeth Ward; Michael J Thun
Journal:  Am J Prev Med       Date:  2008-05       Impact factor: 5.043

6.  Barriers to the provision of smoking cessation services reported by clinicians in underserved communities.

Authors:  Daniel S Blumenthal
Journal:  J Am Board Fam Med       Date:  2007 May-Jun       Impact factor: 2.657

7.  Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science.

Authors:  Laura J Damschroder; David C Aron; Rosalind E Keith; Susan R Kirsh; Jeffery A Alexander; Julie C Lowery
Journal:  Implement Sci       Date:  2009-08-07       Impact factor: 7.327

8.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

9.  Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina and Caucasian women.

Authors:  Hayley S Thompson; Heiddis B Valdimarsdottir; Lina Jandorf; William Redd
Journal:  Patient Educ Couns       Date:  2003-11

10.  Smoking knowledge and behavior in the United States: sociodemographic, smoking status, and geographic patterns.

Authors:  Lila J Finney Rutten; Erik M Augustson; Richard P Moser; Ellen Burke Beckjord; Bradford W Hesse
Journal:  Nicotine Tob Res       Date:  2008-10       Impact factor: 4.244

View more
  4 in total

1.  In-vivo design feedback and perceived utility of a genetically-informed smoking risk tool among current smokers in the community.

Authors:  Jessica L Bourdon; Amelia Dorsey; Maia Zalik; Amanda Pietka; Patricia Salyer; Michael J Bray; Laura J Bierut; Alex T Ramsey
Journal:  BMC Med Genomics       Date:  2021-05-26       Impact factor: 3.063

2.  Evidence-based smoking cessation treatment: a comparison by healthcare system.

Authors:  Jennifer A Lewis; Nicole Senft; Heidi Chen; Kathryn E Weaver; Lucy B Spalluto; Kim L Sandler; Leora Horn; Pierre P Massion; Robert S Dittus; Christianne L Roumie; Hilary A Tindle
Journal:  BMC Health Serv Res       Date:  2021-01-07       Impact factor: 2.655

3.  Proof of Concept of a Personalized Genetic Risk Tool to Promote Smoking Cessation: High Acceptability and Reduced Cigarette Smoking.

Authors:  Alex T Ramsey; Jessica L Bourdon; Michael Bray; Amelia Dorsey; Maia Zalik; Amanda Pietka; Patricia Salyer; Li-Shiun Chen; Timothy B Baker; Marcus R Munafò; Laura J Bierut
Journal:  Cancer Prev Res (Phila)       Date:  2020-09-21

4.  Utility of incorporating a gene-based lung cancer risk test on uptake and adherence in a community-based lung cancer screening pilot study.

Authors:  V K Lam; R J Scott; P Billings; E Cabebe; R P Young
Journal:  Prev Med Rep       Date:  2021-05-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.